- Stocks
- Healthcare
- NYSE: MDT

Price (delayed)

$116.58

Market cap

$156.92B

P/E Ratio

44.33

Dividend/share

$2.28

EPS

$2.63

Enterprise value

$180.51B

Medtronic's quick ratio has decreased by 19% YoY but it has increased by 19% from the previous quarter

The price to earnings (P/E) is 41% higher than the last 4 quarters average of 31.4 and 36% higher than the 5-year quarterly average of 32.7

The EPS has declined by 24% year-on-year and by 20% since the previous quarter

What are the main financial stats of MDT

Market
Valuations
Earnings

Shares outstanding

1.35B

Market cap

$156.92B

Enterprise value

$180.51B

Price to earnings (P/E)

44.33

Price to book (P/B)

3.12

Price to sales (P/S)

5.62

EV/EBIT

46.93

EV/EBITDA

27.68

EV/Sales

6.48

Revenue

$27.87B

EBIT

$3.85B

EBITDA

$6.52B

Free cash flow

$4.75B

Per share
Balance sheet
Liquidity

EPS

$2.63

Free cash flow per share

$3.53

Book value per share

$37.32

Revenue per share

$20.73

TBVPS

$26.97

Total assets

$95.89B

Total liabilities

$45.57B

Debt

$30.01B

Equity

$50.16B

Working capital

$13.97B

Debt to equity

0.6

Current ratio

2.16

Quick ratio

1.63

Net debt/EBITDA

3.62

Margins
Efficiency
Dividend

EBITDA margin

23.4%

Gross margin

64.6%

Net margin

12.7%

Operating margin

12.8%

Return on assets

3.8%

Return on equity

7%

Return on invested capital

8.6%

Return on capital employed

4.6%

Return on sales

13.8%

Dividend yield

1.96%

DPS

$2.28

Payout ratio

86.7%

How has the Medtronic stock price performed over time

Intraday

-1.13%

1 week

-0.2%

1 month

1.7%

1 year

-3.72%

YTD

-0.48%

QTD

-0.48%

How have Medtronic's revenue and profit performed over time

Revenue

$27.87B

Gross profit

$17.99B

Operating income

$3.56B

Net income

$3.54B

Gross margin

64.6%

Net margin

12.7%

The operating income has decreased by 44% YoY and by 11% QoQ

The operating margin has declined by 38% year-on-year and by 10% since the previous quarter

The net income has contracted by 24% YoY and by 20% from the previous quarter

MDT's net margin is down by 20% since the previous quarter and by 16% year-on-year

What is Medtronic's growth rate over time

What is Medtronic stock price valuation

P/E

44.33

P/B

3.12

P/S

5.62

EV/EBIT

46.93

EV/EBITDA

27.68

EV/Sales

6.48

The price to earnings (P/E) is 41% higher than the last 4 quarters average of 31.4 and 36% higher than the 5-year quarterly average of 32.7

The EPS has declined by 24% year-on-year and by 20% since the previous quarter

The stock's price to book (P/B) is 30% more than its 5-year quarterly average of 2.4 and 16% more than its last 4 quarters average of 2.7

MDT's P/S is 37% higher than its 5-year quarterly average of 4.1 and 17% higher than its last 4 quarters average of 4.8

Medtronic's revenue has decreased by 10% YoY

How efficient is Medtronic business performance

The company's return on invested capital fell by 45% YoY and by 11% QoQ

The return on sales has declined by 36% year-on-year and by 10% since the previous quarter

MDT's return on assets is down by 27% year-on-year and by 21% since the previous quarter

Medtronic's return on equity has decreased by 25% YoY and by 20% QoQ

What is MDT's dividend history

DPS

$2.28

Dividend yield

1.96%

Payout ratio

86.7%

Recent dividends

How did Medtronic financials performed over time

The total assets is 110% greater than the total liabilities

The company's current ratio fell by 22% YoY but it rose by 16% QoQ

Medtronic's quick ratio has decreased by 19% YoY but it has increased by 19% from the previous quarter

MDT's debt is 40% smaller than its equity

Medtronic's debt to equity has increased by 18% YoY and by 5% from the previous quarter

MDT's debt is up by 17% year-on-year and by 4.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.